June 2021 Volume 17, Issue 6
Volume 17, Issue 6 | June 2021
June 2021
In this Issue
Infectious Disease
Physicians study their own COVID-19 outbreak
A team of physicians performed double duty as scientists and research subjects for a recent study that cautions against prematurely resuming social activities during the pandemic.
Vaccines: Just Add Water
Scientists developed a new low-cost, on-demand vaccine production platform.
Scientists repurposed an orphan drug to kill blood-feeding tsetse flies
A drug for a rare genetic disorder kills blood-feeding tsetse flies, halting their transmission of deadly parasites.
Platelets take down bacteria with the help of a trusty anti-viral
The common flu treatment, Tamiflu, may help treat lethal bloodstream staph infections.
COVID-19 vaccines: After the injection
What happens after the vaccine is injected into your arm?Tools & Technology
A new tool called rewind finds rare cells primed for drug resistance
A cellular “time machine” identifies cells destined to become drug resistant.
Knocking out HIV: Two Approaches, One Goal
From excising integrated viral sequences to modifying stem cells, CRISPR offers new possibilities for developing HIV treatments.Genomics & Proteomics
"Mythbusters” identified the gene that may cause a rare autoimmune disorder
A group of researchers leveraged their location to tackle questions about the rare autoimmune disorder, Addison’s disease.
You have your mother's eyes — and cells
Fetuses transfer some of their cells to their mother in a phenomenon called microchimerism.Editor's Focus
The new CEO of the La Jolla Institute for Immunology ascended by lifting others
Erica Ollman Saphire brings together scientific competitors to find new antibody therapeutics for COVID-19.
Hibernating animals may help cure complex human disease
Linda Goodman, Co-Founder and CTO of Fauna Bio, compares animal and human genomes to identify new drug targets for heart disease, obesity, and more.Cancer
Cancer cells need fatty acids to survive in the brain
Using a mouse model of breast cancer brain metastasis, researchers showed that tumor cells require fatty acid synthesis to grow, which offers a potential therapeutic target.
Killing cancer cells by stressing them out
A new molecule in Phase 1 clinical trials kills leukemia cells by blocking their ability to repair DNA.
